Danielle Nguyen
General Manager
Danielle Nguyen will be available to meet on the following dates:
Monday, April 13, 2026, from 10 a.m. to 1 p.m. and 4 to 5 p.m.
Friday, April 24, 2026, from 8 a.m. to 10 p.m. and 1 to 2 p.m.
Professional background
Danielle Nguyen has held senior management roles at GSK/Haleon (formerly Pfizer), Kraft Heinz, and Coca-Cola, contributing significantly to business growth, improving operational performance, and enhancing overall competitiveness. Her career has been characterized by the successful implementation of strategies focused on operational excellence, innovation, disciplined execution, and talent development.
Danielle is recognized for her ability to align strategic vision with on-the-ground execution, motivate teams towards common objectives, and deliver sustainable results across safety, quality, productivity, engagement, and cost management. She is also dedicated to mentoring and leadership development, actively supporting the growth of future leaders in the manufacturing and industrial sectors.
Currently, she serves as General Manager at Galderma, where she oversees manufacturing operations and supports the company's mission to advance dermatology for all.
The company
Galderma is a global leader dedicated exclusively to dermatology. With over 40 years of scientific innovation, it offers a comprehensive portfolio of solutions—from dermatological care to therapeutic and aesthetic treatments—aimed at addressing all skin health needs. Operating in more than 100 countries, Galderma relies on a unique integrated strategy and close collaborations with healthcare professionals to meaningfully enhance the quality of life for patients and consumers. Its core mission is to advance dermatology for every individual’s skin health journey.
Visionary and committed to performance, Danielle Nguyen aims to double digital growth, incorporate AI into core operations, improve OEE, accelerate automation, and lead her organization toward becoming the factory of the future.
Expenses related to this virtual initiative are minimal. Nearly all revenues generated are donated to the IRCM Foundation, whose mission is to support basic and clinical research at the Institut de recherches cliniques de Montréal (IRCM).
Researchers at the IRCM, grouped around 4 major themes, are working to deepen our knowledge of almost all the major diseases of our time: cancer, diabetes, cardiovascular, genetic or inflammatory diseases, Alzheimer's and Parkinson's, to name but a few. Physicians at the IRCM Clinic care for patients living with complex or rare diseases that require ultra-specialized follow-up.
